Patients who take a close look at medical science in search of treatments are often appalled by what they discover. On the one hand, there's academic research, a self-contained and self-absorbed universe of its own where data may be internally consistent (on a good day) and robustly reproducible, yet often has little relevance to real-world clinical conditions.

Alzheimer's is a disease without a cure; the number of people afflicted continues to rise, and it is time for bureaucrats in Washington to support brain science research in the hope of finding a cure.

Drug makers aren't chasing blockbusters like Lipitor anymore, or uncovering compounds the same way.

Caring for the age group mostlikely to be afflicted with the disease will cost far more than finding a cure now.

While biopharmaceutical companies may be thought of as mission oriented, they are almost certainly the poster children for adaptation. They need to focus on finding the most pressing relevant issues to help their patients.

In "My Father at 100: A memoir", Ron Reagan attacks his father on several fronts, yet it seemed to lack substance on why he disagreed with him.

The United States should establish the Alzheimer's Solutions Project to ultimately prevent Alzheimer's disease.

The single largest component of Medicaid is long-term care for the elderly, followed by care for the seriously disabled. And the biggest chunk of all is care for what are called the "dual-eligibles," those who qualify for both Medicare and Medicaid.